NEJM August 2026 Carbocisteine or Hypertonic Saline for Acute Respiratory Failure

This clinical study investigated whether two common medications, carbocisteine and hypertonic saline, could reduce the amount of time critically ill patients spend on breathing machines. By analyzing nearly 2,000 participants, researchers determined that neither of these mucoactive agentsshortened the duration of mechanical ventilation compared to standard medical care. Furthermore, the treatments were linked to negative side effects, such as gastrointestinal bleeding and breathing difficulties, rather than patient recovery. Ultimately, the trial concludes that these interventions offer no clinical benefit for acute respiratory failure and may even cause unnecessary harm.